Everyone has heard of CBD and THC and their effects, but did you know there are over 100 cannabinoids in hemp? One cannabinoid in particular, CBG (cannabigerol), is typically present at about 1%, compared to CBD which can make up 20% of hemp, but what is CBG and what impact does it have on the cannabinoid community?
While CBG has not been talked about nearly as much as CBD or THC, this cannabinoid is really starting to make a name for itself and studies are showing that CBG is the next big thing in hemp.
Since it is present in such low levels in most hemp strains, CBG is a minor cannabinoid. Hemp plants first produce CBGA, the precursor to THCA, CBCA and CBDA.
Enzymes in hemp break down CBGA into THCA, CBCA and CBDA. Acids exposed to ultraviolet heat or light become the most common cannabinoids: CBD and THC. CBGA immediately converts to either THCA or CBDA. When more THC is present, less CBD and CBG are created.
In order to yield higher levels of CBG in hemp, growers are experimenting with cross-breeding of plants.
Our bodies have an internal system called the endocannabinoid system, or ECS. The endocannabinoid system is what regulates cannabinoids and their effects on our bodies.
Studies have shown that CBG helps with a multitude of physiological issues:
- Endocannabinoid receptors can be found in eye structures and CBG may help treat glaucoma by reducing pressure.
- One study involving mice found that CBG was effective in combating IBD.
- CBG also was shown to protect neurons in mice with Huntington’s disease.
- CBG is currently being studied as a potential cancer fighter.
- Research in Europe has shown evidence that CBG could be used as an effective antibacterial agent and had success in combating MRSA.
Scientists are very encouraged by CBG and many people are hailing it as the next big thing in cannabis. Many reports are showing that CBG may actually help more with pain and inflammation than CBD.*